← Back to the wire

Sanofi, Regeneron Expand Partnership Worth Up to $8 Billion

Deals·2 articles across 2 outlets

Story updated Rewritten when the story materially grows; the wire is checked every 15 minutesAbout this data

Sanofi and Regeneron Pharmaceuticals are expanding their partnership in a deal that could see the US drugmaker receive as much as $8 billion.

The collaboration aims to enhance their joint efforts in developing innovative therapies and addressing unmet medical needs.

SanofiRegeneron

Sources

Every quote below is verbatim from the article it is attributed to.

SourceReports the news
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.